Newswise -
What and Why: Vision and Traumatic Brain Injury (TBI): A view toward therapeutics
More than 75% of all TBI patients experience visual disorders, including double vision, light sensitivity, difficulty reading print and even vision loss. This interactive session will bring together some of the best minds studying TBI to discuss two important topics: what happens inside the head and eyes of a patient with TBI that leads to symptoms, and the scientific exploration that gives hope for treatments for the debilitating condition.
• Master Sergeant Eric Marts (Retired Army) will share the challenges he has faced — from both TBI and the Department of Veterans Affairs — following his deployment to Iraq in 2005 – 2007.
• Ann McKee of Boston University will discuss her findings about CTE in athletes and veterans.
• Jim Zorn, former quarterback of the Seattle Seahawks, will talk about the need for more research to support veterans, athletes and others whose lives have been devastated by TBI.
Scientists will outline developments in diagnosing TBI earlier and more accurately, new ideas on how to minimize or slow the effects of TBI and possibilities for therapy.
Who: Association for Research in Vision and Ophthalmology
Where: Washington State Convention Center, Seattle, Washington, Skagit 4/5 (The Conference Center Annex)
When: Saturday, April 30, 2015, 10am – 1pm Pacific time
Additional speakers/interview opportunities:
• Randy H. Kardon, MD, PhD, University of Iowa: Do Visual Manifestations of TBI Progress?
• Lee E. Goldstein, MD, PhD, Boston University: Experimental Approach to Neurotrauma and the Eye
• Wing Commander Robert AH Scott, MBBS, FRCS(Ed), FRCOphth, DMi, University of Birmingham, United Kingdom: Potential Therapies Based on Disturbance in Vision
• Elaine R. Peskind, MD, University of Washington: Blast Concussion and Mild TBI in Veterans: Implications for Vision
• Andrew T. Hartwick, OD, PhD, The Ohio State University: The Link between Photophobia and Head Injury
For more information, see arvo.org/TBI.
About ARVO
The Association for Research and Vision in Ophthalmology (ARVO) is the largest eye and vision research organization in the world. Members include nearly 12,000 eye and vision researchers from over 75 countries. ARVO advances research worldwide into understanding the visual system and preventing, treating and curing its disorders. Learn more at arvo.org.
